ATI RN
ATI RN Custom Exams Set 4
1. What is a primary intervention for managing hyperphosphatemia?
- A. Increasing calcium intake
- B. Increasing phosphorus intake
- C. Decreasing calcium intake
- D. Administering phosphate binders
Correct answer: D
Rationale: Administering phosphate binders is a primary intervention for managing hyperphosphatemia. Phosphate binders work by binding phosphorus in the gut, preventing its absorption. Increasing calcium intake (Choice A) is not a primary intervention for hyperphosphatemia and can actually exacerbate the condition by potentially raising calcium levels. Increasing phosphorus intake (Choice B) is contraindicated in hyperphosphatemia. Decreasing calcium intake (Choice C) may help manage hypercalcemia but is not the primary intervention for hyperphosphatemia.
2. The nurse writes a problem of “potential for complication related to ovarian hyperstimulation” for a client who is taking clomiphene (Clomid), an ovarian stimulant. Which intervention should be included in the plan of care?
- A. Instruct the client to delay intercourse until menses
- B. Schedule the client for frequent pelvic sonograms
- C. Explain that the infusion therapy will take 21 days
- D. Discuss that this may cause an ectopic pregnancy
Correct answer: B
Rationale: Frequent pelvic sonograms help monitor for ovarian hyperstimulation, a serious potential side effect of clomiphene. Instructing the client to delay intercourse until menses (Choice A) is not directly related to monitoring for ovarian hyperstimulation. Explaining the duration of infusion therapy (Choice C) is not relevant to monitoring for this specific complication. Discussing the risk of ectopic pregnancy (Choice D) is important, but it is not the most appropriate intervention for monitoring ovarian hyperstimulation.
3. In patients receiving chemotherapy, which nutrient is often supplemented to manage mucositis?
- A. Vitamin E
- B. Vitamin B12
- C. Zinc
- D. Calcium
Correct answer: C
Rationale: Zinc supplementation is often used to manage mucositis in patients receiving chemotherapy. Zinc has been shown to aid in the healing process of mucositis. Vitamin E (Choice A) is not typically used to manage mucositis associated with chemotherapy. Vitamin B12 (Choice B) is essential for nerve function and the formation of red blood cells, but it is not primarily used to manage mucositis. Calcium (Choice D) is important for bone health and nerve function but is not specifically used to manage mucositis.
4. The nurse understands that which are characteristics of anthrax? Select all that apply.
- A. Cutaneous lesions become a black eschar, Flu-like symptoms are a sign of pulmonary anthrax
- B. Cutaneous lesions become a black eschar
- C. Gastrointestinal anthrax causes blood anthrax
- D. Flu-like symptoms are a sign of pulmonary anthrax
Correct answer: A
Rationale: The correct characteristics of anthrax are that cutaneous lesions become a black eschar, and flu-like symptoms are typical of pulmonary anthrax. Choice B is incorrect as it only covers the cutaneous anthrax characteristic and does not include the flu-like symptoms of pulmonary anthrax. Choice C is incorrect as gastrointestinal anthrax does not cause 'blood anthrax,' and Choice D is incorrect as flu-like symptoms are not associated with gastrointestinal anthrax.
5. Which question should the healthcare provider ask when assessing the client for an endocrine dysfunction?
- A. “Have you noticed any pain in your legs when walking?”
- B. “Have you had any unexplained weight loss?”
- C. “Have you noticed any change in your bowel movements?”
- D. “Have you experienced any joint pain or discomfort?”
Correct answer: B
Rationale: The correct answer is B: “Have you had any unexplained weight loss?” Unexplained weight loss can be a significant symptom of various endocrine disorders, such as hyperthyroidism and diabetes. Weight changes are often closely linked to endocrine dysfunction due to the hormonal imbalances affecting metabolism. Choices A, C, and D are less specific to endocrine dysfunction. Pain in the legs, changes in bowel movements, and joint pain or discomfort are symptoms that can be related to various health conditions but are not as indicative of endocrine disorders as unexplained weight loss.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access